NCT01422135 - Pharmacokinetic Study of AG200-15 Transdermal Patch to Three Anatomical Sites in Healthy Females | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 28, 2011

Primary Completion Date

April 30, 2011

Study Completion Date

April 30, 2011

Conditions

Healthy

Interventions

DRUG

AG200-15

A transdermal contraceptive delivery system for levonorgestrel (LNG) and ethinyl estradiol (EE). . A total of 3 patches will be worn during the study. Each patch will be worn for 1 week followed by a patch free week.

Trial Locations (2)

68502

Lincoln

07753

Neptune City